These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7635995)

  • 1. A placebo-controlled evaluation of the effects of buspirone on smoking cessation: differences between high- and low-anxiety smokers.
    Cinciripini PM; Lapitsky L; Seay S; Wallfisch A; Meyer WJ; van Vunakis H
    J Clin Psychopharmacol; 1995 Jun; 15(3):182-91. PubMed ID: 7635995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of buspirone in smoking cessation: a placebo-controlled trial.
    Schneider NG; Olmstead RE; Steinberg C; Sloan K; Daims RM; Brown HV
    Clin Pharmacol Ther; 1996 Nov; 60(5):568-75. PubMed ID: 8941030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buspirone effect on tobacco withdrawal symptoms: a randomized placebo-controlled trial.
    Robinson MD; Pettice YL; Smith WA; Cederstrom EA; Sutherland DE; Davis H
    J Am Board Fam Pract; 1992; 5(1):1-9. PubMed ID: 1561909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of buspirone on withdrawal symptoms associated with smoking cessation.
    Hilleman DE; Mohiuddin SM; Del Core MG; Sketch MH
    Arch Intern Med; 1992 Feb; 152(2):350-2. PubMed ID: 1739365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of buspirone on cigarette withdrawal symptoms and short-term abstinence rates in a smokers clinic.
    West R; Hajek P; McNeill A
    Psychopharmacology (Berl); 1991; 104(1):91-6. PubMed ID: 1882007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buspirone use for smoking cessation.
    Farid P; Abate MA
    Ann Pharmacother; 1998 Dec; 32(12):1362-4. PubMed ID: 9876819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled comparison of buspirone and oxazepam in generalized anxiety.
    Ansseau M; Papart P; Gérard MA; von Frenckell R; Franck G
    Neuropsychobiology; 1990-1991; 24(2):74-8. PubMed ID: 2134114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].
    Lemoine P; Rouillon F; Pouget D
    Encephale; 1996; 22(6):461-7. PubMed ID: 10901839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of two dosing regimens of buspirone in the treatment of outpatients with persistent anxiety.
    Sramek JJ; Frackiewicz EJ; Cutler NR
    Clin Ther; 1997; 19(3):498-506. PubMed ID: 9220214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buspirone effect on tobacco withdrawal symptoms: a pilot study.
    Robinson MD; Smith WA; Cederstrom EA; Sutherland DE
    J Am Board Fam Pract; 1991; 4(2):89-94. PubMed ID: 2028830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the efficacy of buspirone in patients affected by generalized anxiety disorder, shifting to buspirone from prior treatment with lorazepam: a placebo-controlled, double-blind study.
    Delle Chiaie R; Pancheri P; Casacchia M; Stratta P; Kotzalidis GD; Zibellini M
    J Clin Psychopharmacol; 1995 Feb; 15(1):12-9. PubMed ID: 7714222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, controlled trial in primary care patients with generalized anxiety: a comparison between buspirone and oxazepam.
    Strand M; Hetta J; Rosen A; Sörensen S; Malmström R; Fabian C; Marits K; Vetterskog K; Liljestrand AG; Hegen C
    J Clin Psychiatry; 1990 Sep; 51 Suppl():40-5. PubMed ID: 2211567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms.
    Sramek JJ; Tansman M; Suri A; Hornig-Rohan M; Amsterdam JD; Stahl SM; Weisler RH; Cutler NR
    J Clin Psychiatry; 1996 Jul; 57(7):287-91. PubMed ID: 8666569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
    Davidson JR; DuPont RL; Hedges D; Haskins JT
    J Clin Psychiatry; 1999 Aug; 60(8):528-35. PubMed ID: 10485635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled study.
    Sheehan DV; Raj AB; Harnett-Sheehan K; Soto S; Knapp E
    Acta Psychiatr Scand; 1993 Jul; 88(1):1-11. PubMed ID: 8372689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buspirone: anxiolytic?
    Pecknold JC; Familamiri P; Chang H; Wilson R; Alarcia J; McClure DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):639-42. PubMed ID: 2868495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder.
    Lader M; Scotto JC
    Psychopharmacology (Berl); 1998 Oct; 139(4):402-6. PubMed ID: 9809861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pooled, double-blind comparison of the effects of buspirone, diazepam and placebo in women with chronic anxiety.
    Cohn JB; Rickels K
    Curr Med Res Opin; 1989; 11(5):304-20. PubMed ID: 2649317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buspirone in the management of major depression: a placebo-controlled comparison.
    Fabre LF
    J Clin Psychiatry; 1990 Sep; 51 Suppl():55-61. PubMed ID: 2211570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.